|
 Bharat Biotech co-founder and executive chairman Dr Krishna Ella, has been awarded the prestigious Dean’s medal by the Johns Hopkins Bloomberg School of Public Health. The award was presented to Dr Ella during Bloomberg School’s Convocation Ceremony on May 22, 2024, in Baltimore, Maryland, for his leadership, vision and contribution to improving public health.
John Hopkins Bloomberg School of Public Health acknowledges Dr. Ella’s pioneering work, remarkable influence, and determination to develop an indigenous, innovative, and safe vaccines focused on global public health.
On receiving the Dean’s Medal from Johns Hopkins Bloomberg School of Public Health Dr Ella said, “This medal is a global recognition of India’s scientific excellence, and dedicate this medal to Bharat, which has shown remarkable success by advancing science and R&D, to our exemplary team of scientists, and the results of our strong commitment to public.”
Under Dr Ella’s guidance, Bharat Biotech emerged as a leader in global biotechnology and vaccine innovation, with innovative vaccines, manufactured at large scale, and affordable costs. With a portfolio of over 19 vaccines, including the world's first typhoid conjugate vaccine, Typbar TCV, rotavirus vaccine, Rotavac, and Japanese Encephalitis Vaccine, Jenvac. Bharat Biotech has played a critical role in addressing public health challenges in India and worldwide with supplies of more than 9 billion doses till date.
During the Covid-19 pandemic, Bharat Biotech developed Covaxin, India’s first indigenous Covid-19 vaccine in a record time, conducting the largest-ever human clinical trials and peer-reviewed by world-leading medical journals. The vaccine has been distributed globally and Dr Ella now serves as the President of the Indian Vaccine Manufacturers’ Association (IVMA).
Bharat Biotech is developing promising vaccines against Cholera, malaria, tuberculosis, chikungunya, Zika, S. ParatyphiA, S. Typhimurium, S. Enteritidis, etc., which are in crucial clinical trial phases.
Dr Ella is a first-generation entrepreneur, who established Bharat Biotech in the year 1996 and the company emerged as a global leader with 145 patents, 20 vaccines, and bio-therapeutics, delivering more than 9 billion doses of lifesaving vaccines across 125 nations. He is also acknowledged as the father of Genome Valley in Hyderabad, for his significant contributions in developing the vaccine ecosystem, which is now the largest cluster of life sciences in India.
|